GlobeNewswire Inc.··NaAquestive to Unveil Anaphylm Clinical Results at 2026 Allergy Conference
Aquestive to present clinical trial data for Anaphylm, an investigational oral anaphylaxis treatment, at 2026 allergy conference, showing promising safety and efficacy results.
AQSTclinical dataFDA approval